Chronic Imatinib (>3 Years) Therapy after Complete Resection of Primary, High-Risk Gastrointestinal Stromal Tumor (GIST) Is Associated with Low Recurrence

Journal of the American College of Surgeons(2016)

引用 1|浏览6
暂无评分
摘要
Cavnar, Michael J. MD; Balachandran, Vinod P. MD; Chi, Ping MD, PhD; Keohan, Mary L. MD; Tap, William D. MD; DeMatteo, Ronald P. MD, FACS Author Information
更多
查看译文
关键词
tumor,gist,high-risk
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要